Quarterly Result30 Apr 2026, 12:32 pm
Sanofi Consumer Healthcare Q1'26 Revenue ₹2,292 MN, PAT ₹678 MN
AI Summary
Sanofi Consumer Healthcare India Limited (SCHIL) announced its unaudited financial results for the first quarter ended March 31, 2026. The company reported a 33% year-on-year growth in revenue, reaching ₹2,292 million. Domestic sales increased by 15.5%, primarily driven by the successful relaunch of recalled products. Export sales saw a substantial 144% growth, albeit from a low base. Profit After Tax (PAT) for Q1'26 stood at ₹678 million, marking a 36% increase compared to the previous year. Managing Director Himanshu Bakshi emphasized consistent, disciplined execution, with the domestic business outpacing the market and exports making a meaningful contribution.
Key Highlights
- Q1'26 Revenue grew 33% year-on-year to ₹2,292 million.
- Net Profit (PAT) increased 36% year-on-year to ₹678 million.
- Domestic sales rose 15.5%, boosted by product relaunches.
- Export sales surged 144% due to a low comparative base.
- Performance driven by consistent execution and market share gains.